Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

Posted on: 08 Dec 17

CHARLESTON, S.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) (the “Company”) announced today the departure of the Company’s Interim Chief Financial Officer, Jeffrey Whitnell, effective December 7, 2017.  The Company is currently reviewing its resource requirements with respect to its finance department and has commenced a search for Mr. Whitnell's replacement as principal financial officer.

Aeterna Zentaris Inc.
Michael V. Ward
Chief Executive Officer, 843.900.3223

Reilly Connect
Susan J. Reilly
President, 312.600.6780


Last updated on: 10/12/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.